{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:18:10Z","timestamp":1790731090167,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["Code: 3129, HYPOXYTARGET"],"award-info":[{"award-number":["Code: 3129, HYPOXYTARGET"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010623","name":"University of Thessaly","doi-asserted-by":"publisher","award":["5309.17.03"],"award-info":[{"award-number":["5309.17.03"]}],"id":[{"id":"10.13039\/501100010623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbalip.2018.06.015","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T05:10:08Z","timestamp":1529039408000},"page":"1142-1152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Expression of AGPAT2, an enzyme involved in the glycerophospholipid\/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia"],"prefix":"10.1016","volume":"1863","author":[{"given":"Eleni-Anastasia","family":"Triantafyllou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Georgatsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Mylonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Simos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrosyni","family":"Paraskeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2018.06.015_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aaf4405","article-title":"Hypoxic control of metastasis","volume":"352","author":"Rankin","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gde.2010.10.006","article-title":"Hypoxia and energetic tumour metabolism","volume":"21","author":"Brahimi-Horn","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tcb.2017.10.006","article-title":"Cell-autonomous metabolic reprogramming in hypoxia","volume":"28","author":"Schito","year":"2017","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yexcr.2017.03.008","article-title":"New horizons in hypoxia signaling pathways","volume":"356","author":"Pugh","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409238.2013.838205","article-title":"Transcriptional regulation by hypoxia inducible factors","volume":"49","author":"Dengler","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0035","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1242\/jcs.068122","article-title":"Casein kinase 1 regulates human hypoxia-inducible factor HIF-1","volume":"123","author":"Kalousi","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fcell.2016.00011","article-title":"Hypoxia-inducible factors (HIFs) and phosphorylation: impact on stability, localization, and transactivity","volume":"4","author":"Kietzmann","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0045","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/cas.13483","article-title":"Regulatory mechanisms of hypoxia-inducible factor 1 activity: two decades of knowledge","volume":"109","author":"Koyasu","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0050","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1158\/0008-5472.CAN-10-0215","article-title":"eIF2{alpha} kinase PKR modulates the hypoxic response by Stat3-dependent transcriptional suppression of HIF-1{alpha}","volume":"70","author":"Papadakis","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0055","doi-asserted-by":"crossref","first-page":"27620","DOI":"10.1074\/jbc.M803081200","article-title":"Atypical CRM1-dependent nuclear export signal mediates regulation of hypoxia-inducible factor-1alpha by MAPK","volume":"283","author":"Mylonis","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0060","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1096\/fj.10-159806","article-title":"Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1","volume":"24","author":"Gimm","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0065","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1242\/jcs.106682","article-title":"Hypoxia causes triglyceride accumulation by HIF-1-mediated stimulation of lipin 1 expression","volume":"125","author":"Mylonis","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0070","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-07-2489","article-title":"Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1","volume":"68","author":"Furuta","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cmet.2013.11.022","article-title":"Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth","volume":"19","author":"Sun","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0080","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.celrep.2014.08.028","article-title":"HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression","volume":"8","author":"Huang","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.celrep.2014.08.056","article-title":"Fatty acid uptake and lipid storage induced by HIF-1alpha contribute to cell growth and survival after hypoxia-reoxygenation","volume":"9","author":"Bensaad","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0090","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2015.05.030","article-title":"Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia\/reperfusion injury","volume":"63","author":"Hu","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1158\/2159-8290.CD-14-1507","article-title":"HIF2alpha-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma","volume":"5","author":"Qiu","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0100","doi-asserted-by":"crossref","first-page":"15087","DOI":"10.3748\/wjg.v20.i41.15087","article-title":"Hypoxia and fatty liver","volume":"20","author":"Suzuki","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0105","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.bbalip.2017.06.010","article-title":"How lipid droplets \u201cTAG\u201d along: glycerolipid synthetic enzymes and lipid storage","volume":"1862","author":"Wang","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1146\/annurev-biochem-061009-102430","article-title":"Lipid droplets and cellular lipid metabolism","volume":"81","author":"Walther","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0115","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jcb.24757","article-title":"HIF-1alpha expression as a protective strategy of HepG2 cells against fatty acid-induced toxicity","volume":"115","author":"Yoo","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0120","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cellsig.2015.02.017","article-title":"CK1delta restrains lipin-1 induction, lipid droplet formation and cell proliferation under hypoxia by reducing HIF-1alpha\/ARNT complex formation","volume":"27","author":"Kourti","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MOL.0000000000000492","article-title":"The lysophosphatidic acid acyltransferases (acylglycerophosphate acyltransferases) family: one reaction, five enzymes, many roles","volume":"29","author":"Bradley","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078632","article-title":"Lysophosphatidic acid acyltransferase beta regulates mTOR signaling","volume":"8","author":"Blaskovich","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MOL.0b013e328354fcf4","article-title":"Lysophospholipid acyltransferases: 1-acylglycerol-3-phosphate O-acyltransferases. From discovery to disease","volume":"23","author":"Agarwal","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies\u2014new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0150","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/sj.bjc.6602528","article-title":"Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis","volume":"92","author":"Niesporek","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0155","doi-asserted-by":"crossref","first-page":"9415","DOI":"10.1158\/0008-5472.CAN-05-0516","article-title":"Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies","volume":"65","author":"Springett","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0160","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/cncr.22184","article-title":"Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival","volume":"107","author":"Diefenbach","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1476-4598-9-200","article-title":"Transcriptome analysis of human cancer reveals a functional role of heme oxygenase-1 in tumor cell adhesion","volume":"9","author":"Tauber","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014182","article-title":"Lysophosphatidic acid acyltransferase beta (LPAATbeta) promotes the tumor growth of human osteosarcoma","volume":"5","author":"Rastegar","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0175","first-page":"8428","article-title":"Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma","volume":"63","author":"Hideshima","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0180","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1158\/1078-0432.CCR-06-0140","article-title":"Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib","volume":"12","author":"La Rosee","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0185","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20176359","article-title":"MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATbeta in osteosarcoma","volume":"50","author":"Song","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0190","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3892\/ijo.2016.3820","article-title":"Silencing LPAATbeta inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro","volume":"50","author":"Song","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.abb.2013.04.001","article-title":"MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATbeta","volume":"535","author":"Song","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0200","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1038\/sj.onc.1208522","article-title":"Molecular characterization of PS-341 (bortezomib) resistance: implications for overcoming resistance using lysophosphatidic acid acyltransferase (LPAAT)-beta inhibitors","volume":"24","author":"Hideshima","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0205","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1159\/000110460","article-title":"MgcRacGAP interacts with HIF-1alpha and regulates its transcriptional activity","volume":"20","author":"Lyberopoulou","year":"2007","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jhep.2007.12.021","article-title":"2-Oxoglutarate-dependent oxygenases control hepcidin gene expression","volume":"48","author":"Braliou","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0215","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2010.06.038","article-title":"The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions","volume":"398","author":"Mylonis","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0220","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1248\/bpb.b12-00254","article-title":"Negative regulation of adipogenesis by kaempferol, a component of rhizoma polygonati falcatum in 3T3-L1 cells","volume":"35","author":"Park","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0225","doi-asserted-by":"crossref","first-page":"37676","DOI":"10.1074\/jbc.M111.250449","article-title":"Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2: biochemical characterization and inability to rescue hepatic steatosis in Agpat2(\u2212\/\u2212) gene lipodystrophic mice","volume":"286","author":"Agarwal","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0230","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/en.2017-00511","article-title":"Metabolic, reproductive, and neurologic abnormalities in Agpat1-null mice","volume":"158","author":"Agarwal","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0235","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cmet.2009.01.002","article-title":"Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy","volume":"9","author":"Cortes","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0240","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/14728222.7.5.643","article-title":"Lysophosphatidic acid acyltransferase-beta: a novel target for induction of tumour cell apoptosis","volume":"7","author":"Bonham","year":"2003","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0245","first-page":"1067","article-title":"Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells","volume":"2","author":"Coon","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0250","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1158\/1078-0432.CCR-04-2352","article-title":"Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas","volume":"11","author":"Pagel","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbalip.2018.06.015_bb0255","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","article-title":"De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy","volume":"100","author":"Mashima","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbalip.2018.06.015_bb0260","doi-asserted-by":"crossref","first-page":"22583","DOI":"10.1074\/jbc.R114.566091","article-title":"Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR)","volume":"289","author":"Foster","year":"2014","journal-title":"J. Biol. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198118301380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198118301380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T20:05:23Z","timestamp":1576440323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198118301380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1388198118301380"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2018.06.015","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of AGPAT2, an enzyme involved in the glycerophospholipid\/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2018.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}